+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
Menopause Market Report 2023-2033 - Product Thumbnail Image

Menopause Market Report 2023-2033

  • Report
  • May 2023
  • 253 Pages
  • Global
From
Rheumatology Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatology Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
From
Nordic Biotechnology - Industry Report - Product Thumbnail Image

Nordic Biotechnology - Industry Report

  • Report
  • April 2025
  • 370 Pages
  • Denmark, Finland, ... Denmark, Finland, Iceland, Norway, Sweden
From
From
From
Brain metastases - Pipeline Insight, 2024 - Product Thumbnail Image

Brain metastases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 220 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 375 Pages
  • Global
From
From
From
Loading Indicator